{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:24:31Z","timestamp":1793967871525,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":216,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clinsp.2026.101078","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:58:31Z","timestamp":1788364711000},"page":"101078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differential analysis of lung adenocarcinoma and lung squamous cell carcinoma based on serum tumor markers: diagnostic performance and clinical utility"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1073-3645","authenticated-orcid":false,"given":"Zhuoying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7618-7824","authenticated-orcid":false,"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2253-5906","authenticated-orcid":false,"given":"Lichun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7797-3353","authenticated-orcid":false,"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clinsp.2026.101078_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101078_bib0002","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","article-title":"Advances in molecular pathology and therapy of non-small cell lung cancer","volume":"10","author":"Huang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.clinsp.2026.101078_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2024.1611715","article-title":"Targeted therapeutic options in early and metastatic NSCLC-overview","volume":"30","author":"G\u00e1lffy","year":"2024","journal-title":"Pathol Oncol Res"},{"issue":"11","key":"10.1016\/j.clinsp.2026.101078_bib0004","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ccell.2022.09.018","article-title":"Squamous cell lung cancer: current landscape and future therapeutic options","volume":"40","author":"Lau","year":"2022","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.clinsp.2026.101078_bib0005","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41417-025-00934-4","article-title":"Targeting mTORC2 in lung squamous cell carcinoma improves anti-tumor immunity through the PSGL-1-VISTA axis","volume":"32","author":"Ngwa","year":"2025","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101078_bib0006","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4046\/trd.2022.0142","article-title":"Problems in the pathologic diagnosis of suspected lung cancer","volume":"86","author":"Kim","year":"2023","journal-title":"Tuberc Respir Dis"},{"key":"10.1016\/j.clinsp.2026.101078_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2024\/4782618","article-title":"Determination of tumor marker screening for lung cancer using ROC curves","volume":"2024","author":"Dou","year":"2024","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101078_bib0008","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101078_bib0009","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/labmed\/lmac122","article-title":"Association of CEA, NSE, CYFRA 21-1, SCC-Ag, and ProGRP with clinicopathological characteristics and chemotherapeutic outcomes of lung cancer","volume":"54","author":"Bi","year":"2023","journal-title":"Lab Med"},{"issue":"4","key":"10.1016\/j.clinsp.2026.101078_bib0010","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.62347\/TAEI9443","article-title":"Diagnostic efficiency of peripheral tumor serum biomarkers in lung cancer and their correlation with clinicopathological features","volume":"17","author":"Lv","year":"2025","journal-title":"Am J Transl Res"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101078_bib0011","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/03936155241244802","article-title":"Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: a retrospective study","volume":"39","author":"Wu","year":"2024","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.clinsp.2026.101078_bib0012","article-title":"Development and validation of a tumor marker-based model for the prediction of lung cancer: an analysis of a multicenter retrospective study in Shanghai","volume":"14","author":"Hu","year":"2024","journal-title":"China. Front Oncol."},{"issue":"1","key":"10.1016\/j.clinsp.2026.101078_bib0013","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3904\/kjim.1996.11.1.50","article-title":"A comparison of serum CYFRA 21-1 and SCC Ag in the diagnosis of squamous cell lung carcinoma","volume":"11","author":"Kim","year":"1996","journal-title":"Korean J Intern Med"},{"issue":"8","key":"10.1016\/j.clinsp.2026.101078_bib0014","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.21037\/tlcr-24-190","article-title":"CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study","volume":"13","author":"Kataoka","year":"2024","journal-title":"Transl Lung Cancer Res"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101078_bib0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.21037\/tlcr-24-776","article-title":"Predictive value of perioperative carcinoembryonic antigen changes for recurrence in non-small cell lung cancer","volume":"14","author":"Sun","year":"2025","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101078_bib0016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3892\/ol.2016.4588","article-title":"Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways","volume":"12","author":"Frohwitter","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clinsp.2026.101078_bib0017","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev-pathol-012414-040438","article-title":"Protein glycosylation in cancer","volume":"10","author":"Stowell","year":"2015","journal-title":"Annu Rev Pathol"},{"issue":"28","key":"10.1016\/j.clinsp.2026.101078_bib0018","doi-asserted-by":"crossref","first-page":"45345","DOI":"10.18632\/oncotarget.17477","article-title":"A novel serum-based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT)","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.clinsp.2026.101078_bib0019","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.7150\/jca.85846","article-title":"Multi-biomarkers panel in identifying benign and malignant lung diseases and pathological types of lung cancer","volume":"14","author":"Yao","year":"2023","journal-title":"J Cancer"},{"issue":"3","key":"10.1016\/j.clinsp.2026.101078_bib0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.21037\/tlcr-23-855","article-title":"Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel","volume":"13","author":"Izawa","year":"2024","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"10.1016\/j.clinsp.2026.101078_bib0021","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/1354750X.2024.2360038","article-title":"Diagnostic potential of protein serum biomarkers for distinguishing small and non-small cell lung cancer in patients with suspicious lung lesions","volume":"29","author":"Sua","year":"2024","journal-title":"Biomarkers"},{"issue":"2","key":"10.1016\/j.clinsp.2026.101078_bib0022","doi-asserted-by":"crossref","first-page":"398","DOI":"10.21037\/tlcr-23-144","article-title":"Immunotherapy for advanced non-small cell lung cancer with negative programmed death-ligand 1 expression: a literature review","volume":"13","author":"Bai","year":"2024","journal-title":"Transl Lung Cancer Res"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101078_bib0023","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13045-025-01679-1","article-title":"Recent advances in therapeutic strategies for non-small cell lung cancer","volume":"18","author":"Su","year":"2025","journal-title":"J Hematol Oncol"},{"issue":"40","key":"10.1016\/j.clinsp.2026.101078_bib0024","doi-asserted-by":"crossref","first-page":"25036","DOI":"10.1073\/pnas.2006212117","article-title":"Development of a serum miRNA panel for detection of early-stage non-small cell lung cancer","volume":"117","author":"Ying","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"10.1016\/j.clinsp.2026.101078_bib0025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.21037\/atm-23-1572","article-title":"Circulating tumour DNA analysis for early detection of lung cancer: a systematic review","volume":"12","author":"Lam","year":"2024","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.clinsp.2026.101078_bib0026","first-page":"72","article-title":"Exosome autoantibody biomarkers for detection of lung cancer","volume":"1","author":"Thuya","year":"2024","journal-title":"Mil Med Res"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322600205X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S180759322600205X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:26:09Z","timestamp":1793964369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S180759322600205X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"alternative-id":["S180759322600205X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101078","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential analysis of lung adenocarcinoma and lung squamous cell carcinoma based on serum tumor markers: diagnostic performance and clinical utility","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2026.101078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101078"}}